The website and its content are not intended to be viewed and used by French & UK healthcare professionals

Sequential treatment strategy in dyslipidemia vs earlier use of combination therapies: decision-making factors

Sequential treatment strategy in dyslipidemia vs earlier use of combination therapies: decision-making factors

Join the ESC 2021 Satellite Symposium sponsored by Servier on factors important for decision-making in dyslipidemia with Alberto Zambon, Evangelos Liberopoulos and Francois Schiele.

Program:

  • Introduction
    Alberto Zambon
  • Reasons for a sequential treatment strategy in dyslipidemia
    Evangelos Liberopoulos
  • Should we encourage earlier and broader use of combination therapies in dyslipidemia?
    Francois Schiele
  • Discussion
    Zambon, Liberopoulos, Schiele